Nurse Practitioner in Colusa, CA Accepting Medicare
7 Nurse Practitioner nurses found. Showing 1 - 7
 Krista L Taylor, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 173 E Webster St, Colusa, CA 95932 Phone: 530-458-8050 Fax: 530-458-5936 |
Maria Rosario Devega, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 412 4th St, Colusa, CA 95932 Phone: 707-732-8679 |
Ms. Catherine Marie Delay, MSN, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 199 E Webster St, Colusa, CA 95932 Phone: 530-458-5821 Fax: 530-458-3210 |
Oziel Nassif De Rico, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 412 4th St, Colusa, CA 95932 Phone: 707-732-8679 Fax: 707-261-9113 |
Dana Lynn Wolucka, BSN, MSN/FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 717 Bridge St, Colusa, CA 95932 Phone: 530-458-2300 Fax: 530-458-5558 |
Mrs. Pushpa Latta, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 555 Fremont St, Colusa, CA 95932 Phone: 530-458-8635 |
Andrea Michelle Balsley, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 199 E Webster St, Colusa, CA 95932 Phone: 530-473-5641 Fax: 530-473-5675 |
News Archive
Exercising during pregnancy prevents weight gain and illness
Excessive weight gain during pregnancy increases the risk of suffering illnesses such as hypertension and gestational diabetes, or of having a premature birth or a birth by Caesarean; furthermore, it also has negative effects on the newly-born and increases the risk of infants being overweight by 30%.
Study analyzes mortality rates of patients after coronary angioplasty
A team of Mayo Clinic researchers have found that cardiac rehabilitation is associated with significantly reduced mortality rates for patients who have had stents placed to treat blockages in their coronary arteries.
Researchers identify new biochemical pathway that could be a potential target for insulin control
In the final event leading to the development of Type 2 diabetes, the pancreas loses its ability to secrete insulin and clear glucose from the blood. Preventing this breakdown in insulin secretion is a key goal in the fight to reduce the burden of a disease that afflicts an estimated 29 million people in the United States.
FDA provides positive review of InNexus' lead preclinical drug candidate
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
NeoGenomics validates and launches series of NeoTYPE cancer profiling tests
NeoGenomics, Inc., a leading provider of cancer-focused genetic and molecular testing services, announced today that it has validated and launched a series of NeoTYPE cancer profiling tests covering 22 different categories of cancer. Each of these tests is designed to investigate the most common and actionable genomic abnormalities reported for that particular tumor.
› Verified 8 days ago